nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Photosensitivity—Vemurafenib—melanoma	0.0278	0.0308	CcSEcCtD
Dimenhydrinate—Chest tightness—Docetaxel—melanoma	0.0243	0.027	CcSEcCtD
Dimenhydrinate—Wheezing—Bleomycin—melanoma	0.0198	0.0219	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Vemurafenib—melanoma	0.0192	0.0213	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Vemurafenib—melanoma	0.0184	0.0204	CcSEcCtD
Dimenhydrinate—Neuritis—Docetaxel—melanoma	0.0153	0.0169	CcSEcCtD
Dimenhydrinate—Chills—Vemurafenib—melanoma	0.0151	0.0168	CcSEcCtD
Dimenhydrinate—Nasal congestion—Temozolomide—melanoma	0.0137	0.0152	CcSEcCtD
Dimenhydrinate—Chest discomfort—Docetaxel—melanoma	0.0129	0.0143	CcSEcCtD
Dimenhydrinate—Diplopia—Carmustine—melanoma	0.0129	0.0143	CcSEcCtD
Dimenhydrinate—Diplopia—Temozolomide—melanoma	0.0125	0.0138	CcSEcCtD
Dimenhydrinate—Hypotension—Vemurafenib—melanoma	0.0112	0.0124	CcSEcCtD
Dimenhydrinate—Sweating increased—Temozolomide—melanoma	0.0105	0.0116	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vemurafenib—melanoma	0.0104	0.0115	CcSEcCtD
Dimenhydrinate—Fatigue—Vemurafenib—melanoma	0.0103	0.0114	CcSEcCtD
Dimenhydrinate—Constipation—Vemurafenib—melanoma	0.0102	0.0114	CcSEcCtD
Dimenhydrinate—Dysuria—Temozolomide—melanoma	0.0101	0.0112	CcSEcCtD
Dimenhydrinate—Pollakiuria—Temozolomide—melanoma	0.00995	0.011	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Dactinomycin—melanoma	0.00991	0.011	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Temozolomide—melanoma	0.00983	0.0109	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Carmustine—melanoma	0.00974	0.0108	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Temozolomide—melanoma	0.00941	0.0104	CcSEcCtD
Dimenhydrinate—Chills—Bleomycin—melanoma	0.00917	0.0102	CcSEcCtD
Dimenhydrinate—Asthenia—Vemurafenib—melanoma	0.0086	0.00952	CcSEcCtD
Dimenhydrinate—Chills—Dactinomycin—melanoma	0.00855	0.00947	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vemurafenib—melanoma	0.0082	0.00908	CcSEcCtD
Dimenhydrinate—Tinnitus—Temozolomide—melanoma	0.00804	0.0089	CcSEcCtD
Dimenhydrinate—Dizziness—Vemurafenib—melanoma	0.00793	0.00878	CcSEcCtD
Dimenhydrinate—Chills—Temozolomide—melanoma	0.00774	0.00857	CcSEcCtD
Dimenhydrinate—Vomiting—Vemurafenib—melanoma	0.00762	0.00844	CcSEcCtD
Dimenhydrinate—Rash—Vemurafenib—melanoma	0.00756	0.00837	CcSEcCtD
Dimenhydrinate—Dermatitis—Vemurafenib—melanoma	0.00755	0.00836	CcSEcCtD
Dimenhydrinate—Headache—Vemurafenib—melanoma	0.00751	0.00832	CcSEcCtD
Dimenhydrinate—Confusional state—Bleomycin—melanoma	0.00732	0.00811	CcSEcCtD
Dimenhydrinate—Vision blurred—Carmustine—melanoma	0.00732	0.00811	CcSEcCtD
Dimenhydrinate—Tremor—Carmustine—melanoma	0.00728	0.00806	CcSEcCtD
Dimenhydrinate—Agitation—Carmustine—melanoma	0.00714	0.0079	CcSEcCtD
Dimenhydrinate—Nausea—Vemurafenib—melanoma	0.00712	0.00788	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Bleomycin—melanoma	0.00711	0.00787	CcSEcCtD
Dimenhydrinate—Vision blurred—Temozolomide—melanoma	0.00707	0.00783	CcSEcCtD
Dimenhydrinate—Tremor—Temozolomide—melanoma	0.00703	0.00779	CcSEcCtD
Dimenhydrinate—Anorexia—Bleomycin—melanoma	0.00692	0.00767	CcSEcCtD
Dimenhydrinate—Agitation—Temozolomide—melanoma	0.0069	0.00764	CcSEcCtD
Dimenhydrinate—Hypotension—Bleomycin—melanoma	0.00679	0.00751	CcSEcCtD
Dimenhydrinate—Vertigo—Temozolomide—melanoma	0.00674	0.00747	CcSEcCtD
Dimenhydrinate—Convulsion—Carmustine—melanoma	0.00673	0.00745	CcSEcCtD
Dimenhydrinate—Palpitations—Temozolomide—melanoma	0.00663	0.00735	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Dactinomycin—melanoma	0.00663	0.00734	CcSEcCtD
Dimenhydrinate—Paraesthesia—Bleomycin—melanoma	0.00652	0.00722	CcSEcCtD
Dimenhydrinate—Convulsion—Temozolomide—melanoma	0.0065	0.0072	CcSEcCtD
Dimenhydrinate—Anorexia—Dactinomycin—melanoma	0.00646	0.00715	CcSEcCtD
Dimenhydrinate—Confusional state—Carmustine—melanoma	0.00639	0.00708	CcSEcCtD
Dimenhydrinate—Decreased appetite—Bleomycin—melanoma	0.00631	0.00699	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Docetaxel—melanoma	0.00626	0.00693	CcSEcCtD
Dimenhydrinate—Dry mouth—Temozolomide—melanoma	0.00625	0.00692	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Carmustine—melanoma	0.00621	0.00687	CcSEcCtD
Dimenhydrinate—Tachycardia—Carmustine—melanoma	0.00619	0.00685	CcSEcCtD
Dimenhydrinate—Confusional state—Temozolomide—melanoma	0.00618	0.00684	CcSEcCtD
Dimenhydrinate—Anorexia—Carmustine—melanoma	0.00604	0.00669	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Temozolomide—melanoma	0.006	0.00664	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Bleomycin—melanoma	0.00598	0.00663	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Docetaxel—melanoma	0.00596	0.0066	CcSEcCtD
Dimenhydrinate—Hypotension—Carmustine—melanoma	0.00592	0.00656	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Temozolomide—melanoma	0.00592	0.00656	CcSEcCtD
Dimenhydrinate—Decreased appetite—Dactinomycin—melanoma	0.00589	0.00652	CcSEcCtD
Dimenhydrinate—Fatigue—Dactinomycin—melanoma	0.00584	0.00647	CcSEcCtD
Dimenhydrinate—Anorexia—Temozolomide—melanoma	0.00584	0.00647	CcSEcCtD
Dimenhydrinate—Urticaria—Bleomycin—melanoma	0.00577	0.00639	CcSEcCtD
Dimenhydrinate—Insomnia—Carmustine—melanoma	0.00573	0.00635	CcSEcCtD
Dimenhydrinate—Paraesthesia—Carmustine—melanoma	0.00569	0.0063	CcSEcCtD
Dimenhydrinate—Somnolence—Carmustine—melanoma	0.00564	0.00624	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Dactinomycin—melanoma	0.00558	0.00618	CcSEcCtD
Dimenhydrinate—Insomnia—Temozolomide—melanoma	0.00554	0.00614	CcSEcCtD
Dimenhydrinate—Decreased appetite—Carmustine—melanoma	0.00551	0.0061	CcSEcCtD
Dimenhydrinate—Paraesthesia—Temozolomide—melanoma	0.0055	0.00609	CcSEcCtD
Dimenhydrinate—Somnolence—Temozolomide—melanoma	0.00545	0.00603	CcSEcCtD
Dimenhydrinate—Constipation—Carmustine—melanoma	0.00542	0.006	CcSEcCtD
Dimenhydrinate—Dyspepsia—Temozolomide—melanoma	0.00539	0.00597	CcSEcCtD
Dimenhydrinate—Decreased appetite—Temozolomide—melanoma	0.00533	0.0059	CcSEcCtD
Dimenhydrinate—Fatigue—Temozolomide—melanoma	0.00528	0.00585	CcSEcCtD
Dimenhydrinate—Constipation—Temozolomide—melanoma	0.00524	0.0058	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Carmustine—melanoma	0.00522	0.00578	CcSEcCtD
Dimenhydrinate—Asthenia—Bleomycin—melanoma	0.00521	0.00577	CcSEcCtD
Dimenhydrinate—Chills—Docetaxel—melanoma	0.00514	0.0057	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Temozolomide—melanoma	0.00505	0.00559	CcSEcCtD
Dimenhydrinate—Urticaria—Temozolomide—melanoma	0.00487	0.00539	CcSEcCtD
Dimenhydrinate—Asthenia—Dactinomycin—melanoma	0.00486	0.00538	CcSEcCtD
Dimenhydrinate—Diarrhoea—Dactinomycin—melanoma	0.00463	0.00513	CcSEcCtD
Dimenhydrinate—Vomiting—Bleomycin—melanoma	0.00462	0.00511	CcSEcCtD
Dimenhydrinate—Rash—Bleomycin—melanoma	0.00458	0.00507	CcSEcCtD
Dimenhydrinate—Dermatitis—Bleomycin—melanoma	0.00457	0.00507	CcSEcCtD
Dimenhydrinate—Asthenia—Carmustine—melanoma	0.00455	0.00504	CcSEcCtD
Dimenhydrinate—Palpitations—Docetaxel—melanoma	0.00441	0.00488	CcSEcCtD
Dimenhydrinate—Asthenia—Temozolomide—melanoma	0.0044	0.00487	CcSEcCtD
Dimenhydrinate—Diarrhoea—Carmustine—melanoma	0.00434	0.0048	CcSEcCtD
Dimenhydrinate—Convulsion—Docetaxel—melanoma	0.00432	0.00479	CcSEcCtD
Dimenhydrinate—Nausea—Bleomycin—melanoma	0.00431	0.00478	CcSEcCtD
Dimenhydrinate—Vomiting—Dactinomycin—melanoma	0.00431	0.00477	CcSEcCtD
Dimenhydrinate—Rash—Dactinomycin—melanoma	0.00427	0.00473	CcSEcCtD
Dimenhydrinate—Dizziness—Carmustine—melanoma	0.00419	0.00464	CcSEcCtD
Dimenhydrinate—Diarrhoea—Temozolomide—melanoma	0.00419	0.00464	CcSEcCtD
Dimenhydrinate—Dry mouth—Docetaxel—melanoma	0.00416	0.0046	CcSEcCtD
Dimenhydrinate—Confusional state—Docetaxel—melanoma	0.00411	0.00455	CcSEcCtD
Dimenhydrinate—Dizziness—Temozolomide—melanoma	0.00405	0.00449	CcSEcCtD
Dimenhydrinate—Vomiting—Carmustine—melanoma	0.00403	0.00446	CcSEcCtD
Dimenhydrinate—Nausea—Dactinomycin—melanoma	0.00402	0.00446	CcSEcCtD
Dimenhydrinate—Rash—Carmustine—melanoma	0.004	0.00443	CcSEcCtD
Dimenhydrinate—Dermatitis—Carmustine—melanoma	0.00399	0.00442	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Docetaxel—melanoma	0.00399	0.00442	CcSEcCtD
Dimenhydrinate—Tachycardia—Docetaxel—melanoma	0.00398	0.0044	CcSEcCtD
Dimenhydrinate—Headache—Carmustine—melanoma	0.00397	0.0044	CcSEcCtD
Dimenhydrinate—Vomiting—Temozolomide—melanoma	0.00389	0.00431	CcSEcCtD
Dimenhydrinate—Anorexia—Docetaxel—melanoma	0.00388	0.0043	CcSEcCtD
Dimenhydrinate—Rash—Temozolomide—melanoma	0.00386	0.00428	CcSEcCtD
Dimenhydrinate—Dermatitis—Temozolomide—melanoma	0.00386	0.00427	CcSEcCtD
Dimenhydrinate—Headache—Temozolomide—melanoma	0.00384	0.00425	CcSEcCtD
Dimenhydrinate—Hypotension—Docetaxel—melanoma	0.00381	0.00422	CcSEcCtD
Dimenhydrinate—Nausea—Carmustine—melanoma	0.00377	0.00417	CcSEcCtD
Dimenhydrinate—Insomnia—Docetaxel—melanoma	0.00368	0.00408	CcSEcCtD
Dimenhydrinate—Paraesthesia—Docetaxel—melanoma	0.00366	0.00405	CcSEcCtD
Dimenhydrinate—Nausea—Temozolomide—melanoma	0.00364	0.00403	CcSEcCtD
Dimenhydrinate—Somnolence—Docetaxel—melanoma	0.00362	0.00401	CcSEcCtD
Dimenhydrinate—Dyspepsia—Docetaxel—melanoma	0.00359	0.00397	CcSEcCtD
Dimenhydrinate—Decreased appetite—Docetaxel—melanoma	0.00354	0.00392	CcSEcCtD
Dimenhydrinate—Fatigue—Docetaxel—melanoma	0.00351	0.00389	CcSEcCtD
Dimenhydrinate—Constipation—Docetaxel—melanoma	0.00348	0.00386	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Docetaxel—melanoma	0.00336	0.00372	CcSEcCtD
Dimenhydrinate—Asthenia—Docetaxel—melanoma	0.00292	0.00324	CcSEcCtD
Dimenhydrinate—Diarrhoea—Docetaxel—melanoma	0.00279	0.00309	CcSEcCtD
Dimenhydrinate—Dizziness—Docetaxel—melanoma	0.00269	0.00298	CcSEcCtD
Dimenhydrinate—Vomiting—Docetaxel—melanoma	0.00259	0.00287	CcSEcCtD
Dimenhydrinate—Rash—Docetaxel—melanoma	0.00257	0.00284	CcSEcCtD
Dimenhydrinate—Dermatitis—Docetaxel—melanoma	0.00257	0.00284	CcSEcCtD
Dimenhydrinate—Headache—Docetaxel—melanoma	0.00255	0.00283	CcSEcCtD
Dimenhydrinate—Nausea—Docetaxel—melanoma	0.00242	0.00268	CcSEcCtD
Dimenhydrinate—CHRM2—Signaling Pathways—KISS1—melanoma	0.000111	0.00114	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.000111	0.00114	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.000111	0.00114	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GAB2—melanoma	0.000111	0.00114	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GNA11—melanoma	0.000111	0.00114	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.00011	0.00114	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SKI—melanoma	0.000109	0.00113	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCR1—melanoma	0.000109	0.00113	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—IL6—melanoma	0.000108	0.00112	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MC1R—melanoma	0.000108	0.00111	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SKI—melanoma	0.000108	0.00111	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCR1—melanoma	0.000108	0.00111	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—PIK3CA—melanoma	0.000108	0.00111	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT3—melanoma	0.000106	0.0011	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MC1R—melanoma	0.000106	0.00109	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CXCR4—melanoma	0.000106	0.00109	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GNAQ—melanoma	0.000105	0.00108	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT3—melanoma	0.000105	0.00108	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.000105	0.00108	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CXCR4—melanoma	0.000104	0.00107	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GRM1—melanoma	0.000103	0.00106	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCR7—melanoma	0.000103	0.00106	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GNAQ—melanoma	0.000103	0.00106	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCR7—melanoma	0.000102	0.00105	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GRM1—melanoma	0.000102	0.00105	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SUFU—melanoma	0.000101	0.00104	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SUFU—melanoma	9.9e-05	0.00102	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT3—melanoma	9.66e-05	0.000996	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	9.62e-05	0.000991	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT3—melanoma	9.51e-05	0.00098	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RHOB—melanoma	9.39e-05	0.000968	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—BCL2L11—melanoma	9.39e-05	0.000968	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RHOB—melanoma	9.24e-05	0.000952	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—BCL2L11—melanoma	9.24e-05	0.000952	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HDAC6—melanoma	9.02e-05	0.00093	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—EDN1—melanoma	8.94e-05	0.000921	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	8.9e-05	0.000917	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HDAC6—melanoma	8.88e-05	0.000915	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—EDN1—melanoma	8.8e-05	0.000907	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CSF2—melanoma	8.74e-05	0.000901	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CSF2—melanoma	8.6e-05	0.000886	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCR2—melanoma	8.55e-05	0.000882	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—CXCL8—melanoma	8.55e-05	0.000881	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	8.52e-05	0.000878	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCR2—melanoma	8.42e-05	0.000868	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RAC2—melanoma	8.42e-05	0.000867	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—CXCL8—melanoma	8.41e-05	0.000867	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PRKCA—melanoma	8.38e-05	0.000863	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—WNT5A—melanoma	8.28e-05	0.000854	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFC—melanoma	8.28e-05	0.000854	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RAC2—melanoma	8.28e-05	0.000853	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PRKCA—melanoma	8.24e-05	0.00085	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—WNT5A—melanoma	8.15e-05	0.00084	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFC—melanoma	8.15e-05	0.00084	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EDN1—melanoma	8.12e-05	0.000837	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EDN1—melanoma	7.99e-05	0.000823	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CSF2—melanoma	7.93e-05	0.000818	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CSF2—melanoma	7.81e-05	0.000805	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—RAC1—melanoma	7.77e-05	0.0008	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—RAC1—melanoma	7.64e-05	0.000788	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PRKCA—melanoma	7.61e-05	0.000784	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PRKCA—melanoma	7.49e-05	0.000771	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAP2K2—melanoma	7.44e-05	0.000766	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAP2K2—melanoma	7.32e-05	0.000754	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—F2R—melanoma	7.27e-05	0.00075	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—F2R—melanoma	7.16e-05	0.000738	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—RAC1—melanoma	7.05e-05	0.000727	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EDNRB—melanoma	7.04e-05	0.000726	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—RAC1—melanoma	6.94e-05	0.000715	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EDNRB—melanoma	6.93e-05	0.000714	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTK2B—melanoma	6.84e-05	0.000705	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTK2B—melanoma	6.73e-05	0.000694	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GAB2—melanoma	6.65e-05	0.000686	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GNA11—melanoma	6.65e-05	0.000686	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FLT1—melanoma	6.62e-05	0.000683	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CG—melanoma	6.56e-05	0.000676	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GNA11—melanoma	6.55e-05	0.000675	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GAB2—melanoma	6.55e-05	0.000675	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FLT1—melanoma	6.52e-05	0.000672	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CG—melanoma	6.46e-05	0.000665	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FOXO4—melanoma	6.25e-05	0.000645	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCR4—melanoma	6.25e-05	0.000645	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HDAC2—melanoma	6.25e-05	0.000645	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GNAQ—melanoma	6.18e-05	0.000637	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HDAC2—melanoma	6.15e-05	0.000634	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCR4—melanoma	6.15e-05	0.000634	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FOXO4—melanoma	6.15e-05	0.000634	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GNAQ—melanoma	6.09e-05	0.000627	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CG—melanoma	5.96e-05	0.000614	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CG—melanoma	5.86e-05	0.000604	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SYK—melanoma	5.81e-05	0.000599	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CD—melanoma	5.77e-05	0.000594	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SYK—melanoma	5.72e-05	0.00059	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NGFR—melanoma	5.71e-05	0.000588	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ITGAV—melanoma	5.71e-05	0.000588	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT3—melanoma	5.71e-05	0.000588	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CD—melanoma	5.68e-05	0.000585	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ITGAV—melanoma	5.62e-05	0.000579	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT3—melanoma	5.62e-05	0.000579	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NGFR—melanoma	5.62e-05	0.000579	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SOCS1—melanoma	5.28e-05	0.000545	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAP2K1—melanoma	5.27e-05	0.000543	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—S100B—melanoma	5.27e-05	0.000543	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CD—melanoma	5.24e-05	0.00054	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SOCS1—melanoma	5.2e-05	0.000536	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAP2K1—melanoma	5.19e-05	0.000535	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—S100B—melanoma	5.19e-05	0.000535	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CD—melanoma	5.15e-05	0.000531	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ERBB4—melanoma	5.04e-05	0.00052	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CB—melanoma	5.03e-05	0.000518	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN2B—melanoma	5e-05	0.000515	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ERBB4—melanoma	4.96e-05	0.000511	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	4.95e-05	0.00051	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN2B—melanoma	4.92e-05	0.000507	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CD86—melanoma	4.83e-05	0.000498	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CXCL8—melanoma	4.83e-05	0.000498	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EDN1—melanoma	4.8e-05	0.000494	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CD86—melanoma	4.76e-05	0.00049	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CXCL8—melanoma	4.75e-05	0.00049	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EDN1—melanoma	4.72e-05	0.000486	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CSF2—melanoma	4.69e-05	0.000483	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF1—melanoma	4.69e-05	0.000483	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—IL2—melanoma	4.62e-05	0.000476	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CSF2—melanoma	4.61e-05	0.000475	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF1—melanoma	4.61e-05	0.000475	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—E2F1—melanoma	4.59e-05	0.000473	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CB—melanoma	4.57e-05	0.000471	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—IL2—melanoma	4.54e-05	0.000468	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PDGFRA—melanoma	4.54e-05	0.000468	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—E2F1—melanoma	4.51e-05	0.000465	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ITGB3—melanoma	4.49e-05	0.000463	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKCA—melanoma	4.49e-05	0.000463	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CB—melanoma	4.49e-05	0.000463	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PDGFRA—melanoma	4.47e-05	0.00046	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ITGB3—melanoma	4.42e-05	0.000456	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKCA—melanoma	4.42e-05	0.000456	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SPP1—melanoma	4.41e-05	0.000454	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAP2K2—melanoma	4.39e-05	0.000453	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CXCL8—melanoma	4.39e-05	0.000452	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SPP1—melanoma	4.34e-05	0.000447	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAP2K2—melanoma	4.32e-05	0.000445	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CXCL8—melanoma	4.32e-05	0.000445	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL2—melanoma	4.19e-05	0.000432	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TERT—melanoma	4.18e-05	0.000431	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RAC1—melanoma	4.17e-05	0.000429	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL2—melanoma	4.13e-05	0.000425	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TERT—melanoma	4.11e-05	0.000424	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RAC1—melanoma	4.1e-05	0.000422	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HIF1A—melanoma	4e-05	0.000412	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HIF1A—melanoma	3.93e-05	0.000405	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KDR—melanoma	3.82e-05	0.000394	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KDR—melanoma	3.76e-05	0.000387	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FN1—melanoma	3.68e-05	0.000379	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FN1—melanoma	3.62e-05	0.000373	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH1—melanoma	3.6e-05	0.000371	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH1—melanoma	3.54e-05	0.000365	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CD80—melanoma	3.53e-05	0.000363	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KIT—melanoma	3.52e-05	0.000363	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CG—melanoma	3.52e-05	0.000363	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APC—melanoma	3.52e-05	0.000363	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—NRAS—melanoma	3.52e-05	0.000363	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGF—melanoma	3.48e-05	0.000359	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CD80—melanoma	3.47e-05	0.000358	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CG—melanoma	3.46e-05	0.000357	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APC—melanoma	3.46e-05	0.000357	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KIT—melanoma	3.46e-05	0.000357	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—NRAS—melanoma	3.46e-05	0.000357	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGF—melanoma	3.42e-05	0.000353	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAPK3—melanoma	3.37e-05	0.000347	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAPK3—melanoma	3.32e-05	0.000342	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—BRAF—melanoma	3.31e-05	0.000341	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—BRAF—melanoma	3.26e-05	0.000336	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IGF1—melanoma	3.22e-05	0.000332	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAPK1—melanoma	3.21e-05	0.000331	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EGFR—melanoma	3.21e-05	0.000331	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IGF1—melanoma	3.17e-05	0.000327	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAPK1—melanoma	3.16e-05	0.000325	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EGFR—melanoma	3.16e-05	0.000325	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAP2K1—melanoma	3.11e-05	0.000321	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CD—melanoma	3.09e-05	0.000319	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CA—melanoma	3.06e-05	0.000316	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAP2K1—melanoma	3.06e-05	0.000316	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CD—melanoma	3.04e-05	0.000314	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—KRAS—melanoma	3.03e-05	0.000312	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	3.02e-05	0.000311	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—KRAS—melanoma	2.98e-05	0.000307	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF2—melanoma	2.96e-05	0.000305	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF2—melanoma	2.92e-05	0.0003	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CA—melanoma	2.78e-05	0.000287	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MDM2—melanoma	2.77e-05	0.000286	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CA—melanoma	2.74e-05	0.000282	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ERBB2—melanoma	2.73e-05	0.000282	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MDM2—melanoma	2.73e-05	0.000281	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CB—melanoma	2.7e-05	0.000278	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ERBB2—melanoma	2.69e-05	0.000277	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CB—melanoma	2.65e-05	0.000274	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCL8—melanoma	2.59e-05	0.000267	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRAS—melanoma	2.57e-05	0.000265	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCL8—melanoma	2.55e-05	0.000263	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRAS—melanoma	2.53e-05	0.000261	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1B—melanoma	2.53e-05	0.000261	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT1—melanoma	2.5e-05	0.000258	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1B—melanoma	2.49e-05	0.000257	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CASP3—melanoma	2.48e-05	0.000256	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL2—melanoma	2.48e-05	0.000255	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6—melanoma	2.46e-05	0.000254	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT1—melanoma	2.46e-05	0.000254	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CASP3—melanoma	2.44e-05	0.000252	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL2—melanoma	2.44e-05	0.000251	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6—melanoma	2.43e-05	0.00025	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCND1—melanoma	2.41e-05	0.000249	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CTNNB1—melanoma	2.39e-05	0.000246	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCND1—melanoma	2.38e-05	0.000245	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CTNNB1—melanoma	2.35e-05	0.000242	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MMP9—melanoma	2.34e-05	0.000242	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1A—melanoma	2.34e-05	0.000241	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTEN—melanoma	2.33e-05	0.00024	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NFKB1—melanoma	2.32e-05	0.000239	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MMP9—melanoma	2.31e-05	0.000238	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1A—melanoma	2.3e-05	0.000237	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTEN—melanoma	2.29e-05	0.000236	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NFKB1—melanoma	2.28e-05	0.000235	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT1—melanoma	2.27e-05	0.000234	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT1—melanoma	2.24e-05	0.000231	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFA—melanoma	2.11e-05	0.000217	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT3—melanoma	2.08e-05	0.000215	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NRAS—melanoma	2.08e-05	0.000214	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFA—melanoma	2.07e-05	0.000213	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT3—melanoma	2.05e-05	0.000211	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NRAS—melanoma	2.05e-05	0.000211	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK3—melanoma	1.99e-05	0.000205	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK3—melanoma	1.96e-05	0.000202	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MYC—melanoma	1.94e-05	0.0002	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MYC—melanoma	1.91e-05	0.000196	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK1—melanoma	1.89e-05	0.000195	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGFR—melanoma	1.89e-05	0.000195	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK1—melanoma	1.86e-05	0.000192	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGFR—melanoma	1.86e-05	0.000192	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KRAS—melanoma	1.79e-05	0.000184	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KRAS—melanoma	1.76e-05	0.000181	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CA—melanoma	1.64e-05	0.000169	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CA—melanoma	1.62e-05	0.000167	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TP53—melanoma	1.59e-05	0.000164	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TP53—melanoma	1.57e-05	0.000161	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRAS—melanoma	1.52e-05	0.000157	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRAS—melanoma	1.5e-05	0.000154	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6—melanoma	1.46e-05	0.00015	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6—melanoma	1.43e-05	0.000148	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT1—melanoma	1.34e-05	0.000138	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT1—melanoma	1.32e-05	0.000136	CbGpPWpGaD
